Lacy BE - Search Results

1

Rifaximin Treatment for Individual and Multiple Symptoms of Irritable Bowel Syndrome With Diarrhea: An Analysis Using New End Points.

Lacy BE, Chang L, Rao SSC, Heimanson Z, Sayuk GS. Lacy BE, et al. Clin Ther. 2023 Mar;45(3):198-209. doi: 10.1016/j.clinthera.2023.01.010. Epub 2023 Mar 14. Clin Ther. 2023. PMID: 36922331 Free article. Clinical Trial.

2

Irritable bowel syndrome: patients' attitudes, concerns and level of knowledge.

Lacy BE, Weiser K, Noddin L, Robertson DJ, Crowell MD, Parratt-Engstrom C, Grau MV. Lacy BE, et al. Aliment Pharmacol Ther. 2007 Jun 1;25(11):1329-41. doi: 10.1111/j.1365-2036.2007.03328.x. Aliment Pharmacol Ther. 2007. PMID: 17509101 Free article.

3

An Evidence-based Approach to Therapy in IBS-D: A Case Study Compendium.

Chang L, Lacy BE, Spiegel BM. Chang L, et al. Among authors: lacy be. Gastroenterol Hepatol (N Y). 2010 Sep;6(9 Suppl 15):1-12. Gastroenterol Hepatol (N Y). 2010. PMID: 22570639 Free PMC article.

4

An Evidence-Based Look at Misconceptions in the Treatment of Patients with IBS-D.

Lacy BE, Chey WD, Chang L. Lacy BE, et al. Gastroenterol Hepatol (N Y). 2013 Nov;9(11 Suppl 5):1-24. Gastroenterol Hepatol (N Y). 2013. PMID: 24872792 Free PMC article.

5

Bowel Disorders.

Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, Spiller R. Mearin F, et al. Among authors: lacy be. Gastroenterology. 2016 Feb 18:S0016-5085(16)00222-5. doi: 10.1053/j.gastro.2016.02.031. Online ahead of print. Gastroenterology. 2016. PMID: 27144627

6

Review article: an analysis of safety profiles of treatments for diarrhoea-predominant irritable bowel syndrome.

Lacy BE. Lacy BE. Aliment Pharmacol Ther. 2018 Oct;48(8):817-830. doi: 10.1111/apt.14948. Epub 2018 Sep 7. Aliment Pharmacol Ther. 2018. PMID: 30194692 Free PMC article. Review.

7

Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome.

Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P. Ford AC, et al. Among authors: lacy be. Aliment Pharmacol Ther. 2018 Nov;48(10):1044-1060. doi: 10.1111/apt.15001. Epub 2018 Oct 8. Aliment Pharmacol Ther. 2018. PMID: 30294792 Free article.

8

Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials.

Lacy BE, Harris LA, Chang L, Lucak S, Gutman C, Dove LS, Covington PS, Lembo A. Lacy BE, et al. Therap Adv Gastroenterol. 2019 Apr 15;12:1756284819841290. doi: 10.1177/1756284819841290. eCollection 2019. Therap Adv Gastroenterol. 2019. PMID: 31019552 Free PMC article.

9

Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials.

Shah ED, Lacy BE, Chey WD, Chang L, Brenner DM. Shah ED, et al. Among authors: lacy be. Am J Gastroenterol. 2021 Aug 1;116(8):1601-1611. doi: 10.14309/ajg.0000000000001313. Am J Gastroenterol. 2021. PMID: 34047303 Free PMC article. Review.

10

Systematic review and network meta-analysis: efficacy of licensed drugs for abdominal bloating in irritable bowel syndrome with constipation.

Nelson AD, Black CJ, Houghton LA, Lugo-Fagundo NS, Lacy BE, Ford AC. Nelson AD, et al. Among authors: lacy be. Aliment Pharmacol Ther. 2021 Jul;54(2):98-108. doi: 10.1111/apt.16437. Epub 2021 Jun 11. Aliment Pharmacol Ther. 2021. PMID: 34114657 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters